Protalix BioTherapeutics
PLX
#8866
Rank
S$0.18 B
Marketcap
S$2.32
Share price
2.26%
Change (1 day)
-9.45%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): S$0.02295

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is S$0.02568. In 2024 the company made an earnings per share (EPS) of S$0.05136 a decrease over its 2023 EPS that were of S$0.15.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$0.02295-55.32%
2024S$0.05136-66.67%
2023S$0.15-138.71%
2022S-$0.40-50%
2021S-$0.80181.82%
2020S-$0.28-82.11%
2019S-$1.58-31.67%
2018S-$2.31-72.31%
2017S-$8.35124.14%
2016S-$3.72-147.54%
2015S$7.83-290.63%
2014S-$4.116.67%
2013S-$3.85130.77%
2012S-$1.67-69.77%
2011S-$5.5219.44%
2010S-$4.62-12.2%
2009S-$5.2636.67%
2008S-$3.85-37.5%
2007S-$6.1650%
2006S-$4.113.23%
2005S-$3.98138.46%
2004S-$1.67-74%
2003S-$6.42-0%
2002S-$6.42-50%
2001S-$12.84233.33%
2000S-$3.85-84.21%
1999S-$24.40-24%
1998S-$32.10-600%
1997S$6.42-16.67%
1996S$7.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
S-$0.14-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$5.53 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.21 8,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$0.81 3,050.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel